Detalhe da pesquisa
1.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33721561
2.
Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort.
Breast
; 71: 143-149, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37225592
3.
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.
J Clin Oncol
; 41(10): 1849-1863, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36689693
4.
Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.
J Clin Oncol
; 40(12): 1335-1345, 2022 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35061525